Afilaria injectable suspension 1 vial powder + 1 vial solvent 17 ml

AFILARIA Extended Release 3,4 mg/ml | Seasonal antiparasitic management in dogs 

AFILARIA Prolonged Release 3,4 mg/ml is a veterinary medicinal product in powder and solvent form for injectable suspension, indicated for use exclusively in dogs. Its formulation with prolonged-release moxidectin utilizes microsphere technology that allows for the gradual release of the active ingredient after a single subcutaneous administration.

This product is integrated into seasonal veterinary parasite management programs, helping to maintain continuous coverage during periods of peak exposure. Its use should always be preceded by a veterinary evaluation, including negative heartworm tests.

AFILARIA is indicated for dogs from 12 weeks of age. The dosage is adjusted according to the animal's actual weight at the time of treatment and the local epidemiological situation. It is not intended to act on adult parasites and is part of a preventative approach defined by the attending veterinarian.

Key features
– Prolonged-release injectable suspension
– Subcutaneous administration in a single dose
– For use only in dogs
– Can be integrated into seasonal veterinary plans
– Suitable for pregnant dogs under veterinary criteria

General usage instructions
The reconstituted suspension is administered subcutaneously in a single dose, calculated according to the dog's body weight. Preparation and administration must be carried out following the manufacturer's technical instructions and by qualified personnel.

Conservation
After reconstitution, keep refrigerated between 2°C and 8°C and protected from light. Do not freeze.

FAQ

For which dogs is AFILARIA indicated?
For dogs 12 weeks of age and older, always under veterinary supervision.

How often is it administered?
A single administration within the seasonal risk period.

Can it be used on growing puppies?
Yes, by adjusting the dose to the actual weight at the time of treatment.

Is it safe during pregnancy?
It has been shown to be safe in pregnant dogs under veterinary supervision.

Are preliminary tests necessary?
Yes, the dog must test negative for heartworm before use.

Can it cause local reactions?
In some cases, a mild and transient reaction may be observed at the injection site.

Who should manage it?
Only a veterinarian or authorized personnel.